Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What does that mean in the very short PTSC news:

" that Stryker Corporation has purchased an MMP™ Portfolio license from The TPL Group. "

Where we are?

S402005

Share
New Message
Please login to post a reply